- Home
- RAYA vs CASI Comparison
RAYA vs CASI Comparison
Compare RAYA & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- CASI
- Stock Information
- Founded
- RAYA 2019
- CASI 1991
- Country
- RAYA China
- CASI China
- Employees
- RAYA N/A
- CASI N/A
- Industry
- RAYA Metal Fabrications
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- RAYA Consumer Discretionary
- CASI Health Care
- Exchange
- RAYA Nasdaq
- CASI Nasdaq
- Market Cap
- RAYA 103.6M
- CASI 20.5M
- IPO Year
- RAYA 2022
- CASI 1996
- Fundamental
- Price
- RAYA $2.53
- CASI $1.40
- Analyst Decision
- RAYA
- CASI Strong Buy
- Analyst Count
- RAYA 0
- CASI 1
- Target Price
- RAYA N/A
- CASI $4.00
- AVG Volume (30 Days)
- RAYA 548.6K
- CASI 314.4K
- Earning Date
- RAYA 01-01-0001
- CASI 08-15-2025
- Dividend Yield
- RAYA N/A
- CASI N/A
- EPS Growth
- RAYA N/A
- CASI N/A
- EPS
- RAYA N/A
- CASI N/A
- Revenue
- RAYA $30,300,360.00
- CASI $31,368,000.00
- Revenue This Year
- RAYA $20.95
- CASI N/A
- Revenue Next Year
- RAYA N/A
- CASI N/A
- P/E Ratio
- RAYA N/A
- CASI N/A
- Revenue Growth
- RAYA 49.10
- CASI 8.39
- 52 Week Low
- RAYA $0.56
- CASI $1.09
- 52 Week High
- RAYA $3.14
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- RAYA 58.42
- CASI 44.81
- Support Level
- RAYA $2.31
- CASI $1.23
- Resistance Level
- RAYA $2.99
- CASI $1.50
- Average True Range (ATR)
- RAYA 0.41
- CASI 0.12
- MACD
- RAYA 0.01
- CASI 0.03
- Stochastic Oscillator
- RAYA 58.50
- CASI 78.05
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.